Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Nucleic Acids Research
|
October 30, 2007
The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases
Ron Caspi, Hartmut Foerster, Carol A Fulcher, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2008
Discovery of a novel class of PPARdelta partial agonists
Barry G Shearer, Hari S Patel, Andrew N Billin, et al.
Nature Medicine
|
October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Z Hel, D Venzon, M Poudyal, et al.
The Journal of the Kentucky Medical Association
|
March 28, 2001
Stereotactic breast biopsy: a six-year surgical experience
P S Tate, E L Rogers, E M McGee, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Co-crystal structure guided array synthesis of PPARgamma inverse agonists
Ryan P Trump, Jeffrey E Cobb, Barry G Shearer, et al.
Journal of Medicinal Chemistry
|
February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist
Barry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Nucleic Acids Research
|
November 22, 2011
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
Ron Caspi, Tomer Altman, Kate Dreher, et al.
Nucleic Acids Research
|
October 24, 2009
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
Ron Caspi, Tomer Altman, Joseph M Dale, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 19, 2011
Phenoxyacetic acids as PPARδ partial agonists: synthesis, optimization, and in vivo efficacy
Karen A Evans, Barry G Shearer, David D Wisnoski, et al.
Human Gene Therapy
|
February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene
C Dunbar, L Chang, C Mullen, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Nucleic Acids Research
|
October 30, 2007
The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases
Ron Caspi, Hartmut Foerster, Carol A Fulcher, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2008
Discovery of a novel class of PPARdelta partial agonists
Barry G Shearer, Hari S Patel, Andrew N Billin, et al.
Nature Medicine
|
October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Z Hel, D Venzon, M Poudyal, et al.
The Journal of the Kentucky Medical Association
|
March 28, 2001
Stereotactic breast biopsy: a six-year surgical experience
P S Tate, E L Rogers, E M McGee, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Co-crystal structure guided array synthesis of PPARgamma inverse agonists
Ryan P Trump, Jeffrey E Cobb, Barry G Shearer, et al.
Journal of Medicinal Chemistry
|
February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist
Barry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Nucleic Acids Research
|
November 22, 2011
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
Ron Caspi, Tomer Altman, Kate Dreher, et al.
Nucleic Acids Research
|
October 24, 2009
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
Ron Caspi, Tomer Altman, Joseph M Dale, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 19, 2011
Phenoxyacetic acids as PPARδ partial agonists: synthesis, optimization, and in vivo efficacy
Karen A Evans, Barry G Shearer, David D Wisnoski, et al.
Human Gene Therapy
|
February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene
C Dunbar, L Chang, C Mullen, et al.
Page
of 15